Mapping the Evolutionary Space of SARS-CoV-2 Variants to Anticipate Emergence of Subvariants Resistant to COVID-19 Therapeutics
PLOS Computational Biology · 2024
DOI: 10.1371/journal.pcbi.1012215 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2024. Verfasst von Roberth Anthony Rojas Chávez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, United States of America. Hauptthemen laut MEDLINE: SARS-CoV-2, Spike Glycoprotein, Coronavirus, COVID-19, Evolution, Molecular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, amfAR, The Foundation for AIDS Research, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
New sublineages of SARS-CoV-2 variants-of-concern (VOCs) continuously emerge with mutations in the spike glycoprotein. In most cases, the sublineage-defining mutations vary between the VOCs. It is unclear whether these differences reflect lineage-specific likelihoods for mutations at each spike position or the stochastic nature of their appearance. Here we show that SARS-CoV-2 lineages have distinct evolutionary spaces (a probabilistic definition of the sequence states that can be occupied by expanding virus subpopulations). This space can be accurately inferred from the patterns of amino acid variability at the whole-protein level. Robust networks of co-variable sites identify the highest-likelihood mutations in new VOC sublineages and predict remarkably well the emergence of subvariants with resistance mutations to COVID-19 therapeutics. Our studies reveal the contribution of low frequency variant patterns at heterologous sites across the protein to accurate prediction of the changes at each position of interest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, United States of America.
- Department of Industrial and Manufacturing Systems Engineering, Iowa State University, Ames, Iowa, United States of America.
- Center for Systems Immunology, Departments of Immunology and Computational & Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
- Department of Biostatistics, College of Public Health, The University of Iowa, Iowa City, Iowa, United States of America.
- Department of Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States of America.
ORCID-Profile: Roberth Anthony Rojas Chávez, Hillel Haim
Förderung
- NIAID NIH HHS
- amfAR, The Foundation for AIDS Research
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Zitieren
APA
Rojas Chávez, R. A., Fili, M., Han, C., Rahman, S. A., Bicar, I. G. L., Gregory, S., Helverson, A., Hu, G., Darbro, B. W., Das, J., Brown, G. D., & Haim, H. (2024). Mapping the Evolutionary Space of SARS-CoV-2 Variants to Anticipate Emergence of Subvariants Resistant to COVID-19 Therapeutics. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1012215
Vancouver
Rojas Chávez RA, Fili M, Han C, Rahman SA, Bicar IGL, Gregory S, et al. Mapping the Evolutionary Space of SARS-CoV-2 Variants to Anticipate Emergence of Subvariants Resistant to COVID-19 Therapeutics. PLOS Computational Biology. 2024. doi:10.1371/journal.pcbi.1012215
BibTeX
@article{RojasChvez2024,
author = {Rojas Chávez, Roberth Anthony and Fili, Mohammad and Han, Changze and Rahman, Syed A and Bicar, Isaiah G L and Gregory, Sullivan and Helverson, Annika and Hu, Guiping and Darbro, Benjamin W and Das, Jishnu and Brown, Grant D and Haim, Hillel},
title = {Mapping the Evolutionary Space of SARS-CoV-2 Variants to Anticipate Emergence of Subvariants Resistant to COVID-19 Therapeutics},
journal = {PLOS Computational Biology},
year = {2024},
doi = {10.1371/journal.pcbi.1012215}
}
EUVIMED